K. Haddley

685 total citations
29 papers, 551 citations indexed

About

K. Haddley is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, K. Haddley has authored 29 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 6 papers in Oncology. Recurrent topics in K. Haddley's work include Receptor Mechanisms and Signaling (6 papers), Neuroscience and Neuropharmacology Research (4 papers) and Genetics and Neurodevelopmental Disorders (4 papers). K. Haddley is often cited by papers focused on Receptor Mechanisms and Signaling (6 papers), Neuroscience and Neuropharmacology Research (4 papers) and Genetics and Neurodevelopmental Disorders (4 papers). K. Haddley collaborates with scholars based in United Kingdom, United States and Spain. K. Haddley's co-authors include John P. Quinn, Vivien J. Bubb, Ursula M. Paredes, Gerome Breen, Fahad Ali, Mark R. Howard, Faisal R. Ali, Ronaldo Laranjeira, John R. Kelsoe and Adauto Castelo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neurochemistry and Neurobiology of Disease.

In The Last Decade

K. Haddley

29 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Haddley United Kingdom 12 262 213 123 90 61 29 551
Juho Wedenoja Finland 9 216 0.8× 162 0.8× 166 1.3× 78 0.9× 60 1.0× 19 535
Hiroaki Kawasaki Japan 15 398 1.5× 246 1.2× 93 0.8× 102 1.1× 71 1.2× 43 766
Sharon Mexal United States 9 327 1.2× 125 0.6× 154 1.3× 49 0.5× 50 0.8× 12 558
Gijsje J. L. Snijders Netherlands 13 227 0.9× 105 0.5× 71 0.6× 119 1.3× 48 0.8× 24 935
Susanne Jatzke Germany 15 358 1.4× 273 1.3× 168 1.4× 213 2.4× 87 1.4× 15 790
Yael Piontkewitz Israel 14 212 0.8× 141 0.7× 70 0.6× 59 0.7× 79 1.3× 18 857
Adam Torkamanzehi Iran 14 278 1.1× 81 0.4× 136 1.1× 136 1.5× 94 1.5× 32 621
Swarooparani Vadlamudi United States 11 214 0.8× 115 0.5× 120 1.0× 38 0.4× 63 1.0× 15 714
Mari Kondo Japan 15 351 1.3× 140 0.7× 169 1.4× 30 0.3× 126 2.1× 41 726
Karen M. J. van Loo Germany 15 320 1.2× 231 1.1× 89 0.7× 85 0.9× 39 0.6× 35 595

Countries citing papers authored by K. Haddley

Since Specialization
Citations

This map shows the geographic impact of K. Haddley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Haddley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Haddley more than expected).

Fields of papers citing papers by K. Haddley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Haddley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Haddley. The network helps show where K. Haddley may publish in the future.

Co-authorship network of co-authors of K. Haddley

This figure shows the co-authorship network connecting the top 25 collaborators of K. Haddley. A scholar is included among the top collaborators of K. Haddley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Haddley. K. Haddley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Powell, Timothy R., K. Haddley, Peter McGuffin, et al.. (2014). Mood‐stabilizers differentially affect housekeeping gene expression in human cells. International Journal of Methods in Psychiatric Research. 23(2). 279–288. 13 indexed citations
2.
Haddley, K.. (2014). Turoctocog alfa for the treatment of hemophilia A. Drugs of today. 50(2). 121–121. 4 indexed citations
3.
Haddley, K.. (2014). Vedolizumab for the treatment of inflammatory bowel disease. Drugs of today. 50(4). 309–309. 6 indexed citations
4.
Haddley, K.. (2013). Trastuzumab emtansine for the treatment of HER2-positive metastaticbreast cancer. Drugs of today. 49(11). 701–701. 24 indexed citations
5.
Haddley, K.. (2013). Alipogene tiparvovec for the treatment of lipoprotein lipasedeficiency. Drugs of today. 49(3). 161–161. 17 indexed citations
6.
Haddley, K.. (2012). Brentuximab vedotin: its role in the treatment of anaplastic largecell and Hodgkin's lymphoma. Drugs of today. 48(4). 259–259. 10 indexed citations
7.
Paredes, Ursula M., Vivien J. Bubb, K. Haddley, Gabriele A. Macho, & John P. Quinn. (2011). An evolutionary conserved region (ECR) in the human dopamine receptor D4 gene supports reporter gene expression in primary cultures derived from the rat cortex. BMC Neuroscience. 12(1). 46–46. 5 indexed citations
8.
Paredes, Ursula M., Vivien J. Bubb, K. Haddley, Gabriele A. Macho, & John P. Quinn. (2011). Intronic Tandem Repeat in the Serotonin Transporter Gene in Old World Monkeys: a New Transcriptional Regulator?. Journal of Molecular Neuroscience. 47(2). 401–407. 2 indexed citations
9.
10.
Haddley, K., et al.. (2011). Activity-Dependent Neuroprotective Protein Modulates Its Own Gene Expression. Journal of Molecular Neuroscience. 46(1). 33–39. 18 indexed citations
11.
Haddley, K.. (2011). Mipomersen sodium: A new option for the treatment of familialhypercholesterolemia. Drugs of today. 47(12). 891–891. 6 indexed citations
12.
Gillies, Stuart, K. Haddley, Gregory M. Jacobson, et al.. (2010). Distinct Gene Expression Profiles Directed by the Isoforms of the Transcription Factor Neuron-Restrictive Silencer Factor in Human SK-N-AS Neuroblastoma Cells. Journal of Molecular Neuroscience. 44(2). 77–90. 9 indexed citations
13.
Ali, Fahad, K. Haddley, & John P. Quinn. (2010). Assessing the Impact of Genetic Variation on Transcriptional Regulation In Vitro. Methods in molecular biology. 628. 195–214. 1 indexed citations
14.
Haddley, K.. (2010). rAAV2-CBSB-hRPE65. Drugs of the Future. 35(3). 173–173. 1 indexed citations
15.
Ali, Fahad, K. Haddley, Ursula M. Paredes, et al.. (2009). Combinatorial interaction between two human serotonin transporter gene variable number tandem repeats and their regulation by CTCF. Journal of Neurochemistry. 112(1). 296–306. 59 indexed citations
16.
17.
MacKenzie, Alasdair, et al.. (2007). Generation of a transgenic model to address regulation and function of the human neurokinin 1 receptor (NK1R). Neuropeptides. 41(4). 195–205. 2 indexed citations
18.
Thippeswamy, Thimmasettappa, K. Haddley, Mark R. Howard, et al.. (2006). NO‐cGMP mediated galanin expression in NGF‐deprived or axotomized sensory neurons. Journal of Neurochemistry. 100(3). 790–801. 19 indexed citations
19.
Chandler, Kate, K. Haddley, Mark R. Howard, et al.. (2006). Regulation and role of REST and REST4 variants in modulation of gene expression in in vivo and in vitro in epilepsy models. Neurobiology of Disease. 24(1). 41–52. 74 indexed citations
20.
Gerrard, Lesley, Mark R. Howard, Trevor Paterson, et al.. (2005). A proximal E-box modulates NGF effects on rat PPT-A promoter activity in cultured dorsal root ganglia neurones. Neuropeptides. 39(5). 475–483. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026